Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci

Multidrug-resistant enterococci are major causes of hospital-acquired infections. Immunotherapy with monoclonal antibodies (MAbs) targeting bacterial antigens would be a valuable treatment option in this setting. Here, we describe the development of two MAbs through hybridoma technology that target...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalfopoulou, Ermioni, Laverde, Diana, Miklic, Karmela, Romero-Saavedra, Felipe, Malic, Suzana, Carboni, Filippo, Adamo, Roberto, Lenac Rovis, Tihana, Jonjic, Stipan, Huebner, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704603/
https://www.ncbi.nlm.nih.gov/pubmed/31285252
http://dx.doi.org/10.1128/IAI.00276-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704603/
https://www.ncbi.nlm.nih.gov/pubmed/31285252
http://dx.doi.org/10.1128/IAI.00276-19

Ejemplares similares